探索用于冠状腺瘤治疗的腺类型:体外和体内洞察力
Marion Lenté1, Juliette Aury-Landas1,2, Mahdia Taieb1
1Université de Caen Normandie, UR7451 BioConnect, 14000 Caen, France.
Molecular therapy. Nucleic acids
|August 14, 2025
概括
新的研究表明,克拉德里宾和克洛法拉宾,腺类型,通过诱导亡,有效地治疗冠状腺瘤 (CSs). 这些已被批准用于其他疾病的药物,有望在CS治疗中重新使用.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- Dagiti chondrosarcomas (CSs) ket agpakita ti resistance iti kadawyan a chemotherapy ken radiotherapy.
- 迫切需要新的治疗策略来有效治疗CS.
研究的目的:
- 为了研究腺类型的治疗潜力,用于冠状动脉瘤治疗.
- 验证克拉迪宾和克洛法拉宾作为在CS治疗中重新使用的有希望的候选药物.
主要方法:
- 在2D和3D模型的使用中,对五种腺类型的腺类型在状骨肉瘤细胞系上的体外评估.
- 评估细胞活力,细胞亡和细胞循环.
- 化合物的体内测试在异种移植胆固醇瘤小鼠模型中.
主要成果:
- 四种腺类比物显著降低了软骨肉瘤细胞活力.
- 克拉德里宾和克洛法拉宾通过在2D和3D模型中诱导亡,证明了强烈的疗效.
- 在体内研究证实了克拉迪宾和克洛法拉宾的实质性抗瘤作用.
结论:
- 克拉德里宾和克洛法拉宾在临床前冠状腺癌模型中有效.
- 这些经FDA批准的药物显示出在软骨肉瘤治疗中重新使用的潜力.
- 进一步的临床试验是有必要的,以评估cladribine和clofarabine对于chondrosarcoma患者.
相关概念视频
01:26Heart Failure Drugs: Inotropic Agents
722
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
722
01:28Structure-Activity Relationships and Drug Design
1.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.0K
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
880
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
880
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
647
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
647
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.3K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.3K
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.0K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.0K